• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估小儿非酒精性脂肪肝疾病筛查的可行性。

Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease.

机构信息

Department of Paediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers, Location Academic Medical Center/Emma Children's Hospital, University of Amsterdam, Amsterdam, The Netherlands.

Amsterdam Reproduction & Development Research Institute, Amsterdam University Medical Centers, Location Academic Medical Center/Emma Children's Hospital, Amsterdam, The Netherlands.

出版信息

Acta Paediatr. 2022 Dec;111(12):2408-2415. doi: 10.1111/apa.16502. Epub 2022 Aug 7.

DOI:10.1111/apa.16502
PMID:35899429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9804620/
Abstract

AIM

To evaluate the feasibility of screening for non-alcoholic fatty liver disease (NAFLD) in clinical practice and the acceptance of a screening strategy, and to identify factors that determine compliance.

METHODS

A screening protocol, based on alanine aminotransferase measurement and introduced to healthcare workers of Dutch outpatient obesity clinics in 2017, was evaluated. Medical files of children who visited the largest outpatient obesity clinic between 2017 and 2020 were evaluated. Focus group discussions (FGDs) were conducted with 14 healthcare workers who had been using the screening protocol.

RESULTS

Screening for NAFLD was performed in 477/571 (84%) of the children. Loss of follow-up was the major reason for inadequate screening. Follow-up was performed in 81/134 children with an abnormal screening result (61%). The FGDs indicated 13 barriers for screening, regarding guideline- and knowledge-related issues.

CONCLUSION

Screening for NAFLD was performed in the vast majority of the children. However, adherence to the guideline after an abnormal initial screening result needs to be improved. This can be achieved by improving the loss of follow-up of patients' and physicians' awareness of the relevance of mildly elevated ALT levels.

摘要

目的

评估在临床实践中筛查非酒精性脂肪性肝病(NAFLD)的可行性和对筛查策略的接受程度,并确定决定依从性的因素。

方法

评估了 2017 年向荷兰门诊肥胖诊所的医疗保健工作者引入的基于丙氨酸氨基转移酶测量的筛查方案。评估了 2017 年至 2020 年间访问最大门诊肥胖诊所的儿童的医疗档案。对 14 名使用筛查方案的医疗保健工作者进行了焦点小组讨论(FGD)。

结果

对 571 名儿童中的 477 名(84%)进行了 NAFLD 筛查。失访是筛查不充分的主要原因。对 134 名筛查结果异常的儿童中的 81 名(61%)进行了随访。FGD 表明筛查存在 13 个障碍,涉及指南和知识相关问题。

结论

对绝大多数儿童进行了 NAFLD 筛查。然而,需要提高对异常初始筛查结果的指南遵循性。这可以通过提高患者和医生对轻度升高的 ALT 水平相关性的认识来实现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/9804620/4a0091ad010f/APA-111-2408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/9804620/c1035dcf4257/APA-111-2408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/9804620/4a0091ad010f/APA-111-2408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/9804620/c1035dcf4257/APA-111-2408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca00/9804620/4a0091ad010f/APA-111-2408-g002.jpg

相似文献

1
Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease.评估小儿非酒精性脂肪肝疾病筛查的可行性。
Acta Paediatr. 2022 Dec;111(12):2408-2415. doi: 10.1111/apa.16502. Epub 2022 Aug 7.
2
Survey on screening for paediatric non-alcoholic fatty liver disease in clinical practice in Dutch hospitals.荷兰医院临床实践中儿童非酒精性脂肪性肝病筛查调查
Acta Paediatr. 2020 Nov;109(11):2388-2393. doi: 10.1111/apa.15294. Epub 2020 Apr 20.
3
Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.儿科胃肠病学评估:从初级保健转介的超重和肥胖儿童疑似非酒精性脂肪肝疾病。
Aliment Pharmacol Ther. 2013 Nov;38(10):1267-77. doi: 10.1111/apt.12518. Epub 2013 Oct 1.
4
Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction.按肥胖程度分层,而不是按年龄分层,可以确定更高比例的儿童有患非酒精性脂肪肝和代谢功能障碍的风险。
Pediatr Obes. 2022 Mar;17(3):e12862. doi: 10.1111/ijpo.12862. Epub 2021 Oct 18.
5
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.筛查试验 ALT 和超声对儿童非酒精性脂肪性肝病的诊断准确性比较。
Eur J Pediatr. 2019 Jun;178(6):863-870. doi: 10.1007/s00431-019-03362-3. Epub 2019 Mar 22.
6
Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.肥胖儿童中非酒精性脂肪性肝病(NAFLD)的预测因素
J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):247-253. doi: 10.1515/jpem-2019-0403.
7
Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.学龄儿童非酒精性脂肪性肝病的患病率、危险因素及预测因素:埃及亚历山大市一项基于医院的研究
Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.
8
Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.基于地中海生活方式的干预对非酒精性脂肪性肝病患者临床特征的改善:一项随机对照临床试验。
Br J Nutr. 2018 Jul;120(2):164-175. doi: 10.1017/S000711451800137X.
9
[Detecting non-alcoholic fatty liver in children with owerweight and obesity.].[检测超重和肥胖儿童的非酒精性脂肪肝。]
Rev Med Inst Mex Seguro Soc. 2021 Nov 1;59(6):465-472.
10
Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.非酒精性脂肪性肝病患儿肝组织学异常与丙氨酸氨基转移酶正常或轻度升高。
J Pediatr. 2014 Apr;164(4):707-713.e3. doi: 10.1016/j.jpeds.2013.10.071. Epub 2013 Dec 19.

引用本文的文献

1
Call to action - pediatric MASLD requires immediate attention to curb health crisis.行动呼吁——儿童非酒精性脂肪性肝病相关代谢功能障碍需要立即引起关注,以遏制健康危机。
Hepatology. 2025 Jun 23. doi: 10.1097/HEP.0000000000001440.

本文引用的文献

1
Alternative Etiologies of Liver Disease in Children With Suspected NAFLD.疑似非酒精性脂肪性肝病儿童的肝脏疾病替代病因。
Pediatrics. 2021 Apr;147(4). doi: 10.1542/peds.2020-009829.
2
Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.儿童非酒精性脂肪性肝病的发病率:2009-2018 年。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-0771.
3
Can Baseline Characteristics be Used to Predict Liver Disease Outcomes in Pediatric Nonalcoholic Fatty Liver Disease?基线特征能否用于预测儿童非酒精性脂肪性肝病的肝脏疾病结局?
Obesity (Silver Spring). 2021 Jan;29(1):171-176. doi: 10.1002/oby.22999. Epub 2020 Nov 13.
4
Survey on screening for paediatric non-alcoholic fatty liver disease in clinical practice in Dutch hospitals.荷兰医院临床实践中儿童非酒精性脂肪性肝病筛查调查
Acta Paediatr. 2020 Nov;109(11):2388-2393. doi: 10.1111/apa.15294. Epub 2020 Apr 20.
5
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
6
Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study.基于人群队列样本的非酒精性脂肪性肝病低知晓率:CARDIA 研究。
J Gen Intern Med. 2019 Dec;34(12):2772-2778. doi: 10.1007/s11606-019-05340-9. Epub 2019 Oct 8.
7
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.一项关于欧洲对非酒精性脂肪性肝病公共卫生应对措施的横断面研究。
J Hepatol. 2020 Jan;72(1):14-24. doi: 10.1016/j.jhep.2019.08.027. Epub 2019 Sep 10.
8
Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease.筛查试验 ALT 和超声对儿童非酒精性脂肪性肝病的诊断准确性比较。
Eur J Pediatr. 2019 Jun;178(6):863-870. doi: 10.1007/s00431-019-03362-3. Epub 2019 Mar 22.
9
Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.儿童肥胖中非酒精性脂肪肝疾病的流行率。
J Pediatr. 2019 Apr;207:64-70. doi: 10.1016/j.jpeds.2018.11.021. Epub 2018 Dec 14.
10
Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study.
Hong Kong Med J. 2018 Aug;24 Suppl 4(4):12-15.